Sabra Healthcare REIT (NASDAQ:SBRA) Issues FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.530-1.550 for the period, compared to the consensus EPS estimate of 1.500. The company issued revenue guidance of -.

Sabra Healthcare REIT Stock Up 4.4%

Shares of NASDAQ SBRA opened at $20.89 on Tuesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $21.28. The business has a 50-day moving average of $19.59 and a two-hundred day moving average of $19.76. The company has a market capitalization of $5.27 billion, a price-to-earnings ratio of 33.13, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts forecast that Sabra Healthcare REIT will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.7%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is 190.48%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on SBRA shares. Citigroup downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $24.00 to $19.00 in a research note on Monday, June 22nd. Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Raymond James Financial initiated coverage on shares of Sabra Healthcare REIT in a report on Wednesday, June 17th. They issued an “underperform” rating on the stock. Finally, Scotiabank dropped their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Five research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $21.45.

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors have recently made changes to their positions in the business. Corient Private Wealth LLC bought a new position in Sabra Healthcare REIT in the 4th quarter worth approximately $266,000. Mercer Global Advisors Inc. ADV grew its stake in shares of Sabra Healthcare REIT by 14.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 66,869 shares of the real estate investment trust’s stock worth $1,267,000 after acquiring an additional 8,411 shares during the last quarter. EP Wealth Advisors LLC acquired a new position in Sabra Healthcare REIT during the 4th quarter valued at $300,000. Mackenzie Financial Corp boosted its holdings in Sabra Healthcare REIT by 688.3% in the 4th quarter. Mackenzie Financial Corp now owns 128,367 shares of the real estate investment trust’s stock valued at $2,433,000 after purchasing an additional 112,084 shares during the period. Finally, NewEdge Advisors LLC boosted its holdings in Sabra Healthcare REIT by 13.3% in the 4th quarter. NewEdge Advisors LLC now owns 16,066 shares of the real estate investment trust’s stock valued at $304,000 after purchasing an additional 1,886 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.